Quadrant Capital Group’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-529
| Closed | -$3.97K | – | 1478 |
|
|
2025
Q1 | $3.97K | Hold |
529
| – | – | ﹤0.01% | 2400 |
|
|
2024
Q4 | $3.98K | Hold |
529
| – | – | ﹤0.01% | 2359 |
|
|
2024
Q3 | $4.02K | Hold |
529
| – | – | ﹤0.01% | 2364 |
|
|
2024
Q2 | $3.27K | Sell |
529
-156
| -23% | -$964 | ﹤0.01% | 2393 |
|
|
2024
Q1 | $3.48K | Buy |
685
+22
| +3% | +$112 | ﹤0.01% | 2401 |
|
|
2023
Q4 | $3.97K | Buy |
663
+330
| +99% | +$1.98K | ﹤0.01% | 2336 |
|
|
2023
Q3 | $2.36K | Buy |
+333
| New | +$2.36K | ﹤0.01% | 2350 |
|
|
2023
Q2 | – | Sell |
-211
| Closed | -$1.76K | – | 2696 |
|
|
2023
Q1 | $1.76K | Buy |
+211
| New | +$1.76K | ﹤0.01% | 2449 |
|